Prestige Biologics (Korea) Probability of Future Stock Price Finishing Under 3350.0
| 334970 Stock | KRW 4,550 130.00 2.78% |
Prestige |
Prestige Biologics Target Price Odds to finish below 3350.0
The tendency of Prestige Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to W 3,350 or more in 90 days |
| 4,550 | 90 days | 3,350 | near 1 |
Based on a normal probability distribution, the odds of Prestige Biologics to drop to W 3,350 or more in 90 days from now is near 1 (This Prestige Biologics Co probability density function shows the probability of Prestige Stock to fall within a particular range of prices over 90 days) . Probability of Prestige Biologics price to stay between W 3,350 and its current price of W4550.0 at the end of the 90-day period is under 4.
Assuming the 90 days trading horizon Prestige Biologics Co has a beta of -0.11. This suggests as returns on the benchmark increase, returns on holding Prestige Biologics are expected to decrease at a much lower rate. During a bear market, however, Prestige Biologics Co is likely to outperform the market. Additionally Prestige Biologics Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Prestige Biologics Price Density |
| Price |
Predictive Modules for Prestige Biologics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Prestige Biologics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Prestige Biologics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Prestige Biologics is not an exception. The market had few large corrections towards the Prestige Biologics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Prestige Biologics Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Prestige Biologics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.37 | |
β | Beta against Dow Jones | -0.11 | |
σ | Overall volatility | 802.35 | |
Ir | Information ratio | -0.1 |
Prestige Biologics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Prestige Biologics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Prestige Biologics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Prestige Biologics generated a negative expected return over the last 90 days | |
| Prestige Biologics has high historical volatility and very poor performance | |
| The company reported the revenue of 3.23 B. Net Loss for the year was (39.38 B) with loss before overhead, payroll, taxes, and interest of (2.88 M). | |
| Prestige Biologics Co has accumulated about 36.77 B in cash with (25.87 B) of positive cash flow from operations. |
Prestige Biologics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Prestige Stock often depends not only on the future outlook of the current and potential Prestige Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Prestige Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 47.2 M | |
| Cash And Short Term Investments | 36.8 B |
Prestige Biologics Technical Analysis
Prestige Biologics' future price can be derived by breaking down and analyzing its technical indicators over time. Prestige Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Prestige Biologics Co. In general, you should focus on analyzing Prestige Stock price patterns and their correlations with different microeconomic environments and drivers.
Prestige Biologics Predictive Forecast Models
Prestige Biologics' time-series forecasting models is one of many Prestige Biologics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Prestige Biologics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Prestige Biologics
Checking the ongoing alerts about Prestige Biologics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Prestige Biologics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Prestige Biologics generated a negative expected return over the last 90 days | |
| Prestige Biologics has high historical volatility and very poor performance | |
| The company reported the revenue of 3.23 B. Net Loss for the year was (39.38 B) with loss before overhead, payroll, taxes, and interest of (2.88 M). | |
| Prestige Biologics Co has accumulated about 36.77 B in cash with (25.87 B) of positive cash flow from operations. |
Other Information on Investing in Prestige Stock
Prestige Biologics financial ratios help investors to determine whether Prestige Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prestige with respect to the benefits of owning Prestige Biologics security.